iRhythm to acquire Vital Connect for $287.5M in cash and stock

iRhythm Holdings, Inc.

Total consideration $287.5M: $237.5M cash + $50M in iRhythm common stock.
Merger expected to close by end of 2026, subject to Vital Connect stockholder approval and HSR clearance.
iRhythm provides interim funding of up to $30M (initial $10M) to Vital Connect pre-close.
Reverse termination fee of $9M payable by iRhythm if deal fails due to antitrust issues.
Vital Connect will survive as a wholly owned subsidiary of iRhythm Technologies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.